ArticleEuropean journal of clinical pharmacology2026
Response to comment on "CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy".
Yande Kasolo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.